Tuesday, September 27, 2011

Quark Pharma pulls IPO plans again

Quark Pharmaceuticals Inc., which develops RNA interference drugs, withdrew initial public offering plans to raise up to $20 million.
The company reportedly did not obtain favorable terms and could raise additional private funding, according to a Dow Jones VentureWire story.

No comments:

Post a Comment